CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale CEO sold 150,000 shares at an average $40.15 ($6,022,749)
- 4 Open-market buy Director bought 1,562,500 shares at $40.00 ($62,500,000)
- 4 Open-market sale Controller & PAO sold 33,112 shares at an average $39.73 ($1,315,443)
- 4 Open-market sale Director sold 30,000 shares at an average $37.80 ($1,133,860)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 421,756 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 10,000 shares at $20.00 ($200,041)
- 4 Open-market buy Director bought 11,764,705 shares at $17.00 ($199,999,985)
Page 14 of 35 · 686 filings